Company
Ricovr
Point - of - care saliva based diagnostic platform
Also known as Ricovr Healthcare Inc
- Business model
- B2B
- Legal name
- Ricovr Healthcare Inc
Claim, correct or request removal
Record updated 29 September 2026
About
The Future of Diagnostics is Fluid. Ricovr’s portable, saliva-based platform delivers ultra-sensitive, high-quality diagnostics at the point of need. Our proven THC test for workplace safety validates the technology, establishing a scalable foundation for expansion into multiple high-value health markets. Precision by Design Our proprietary platform utilizes ultra-sensitive fiber optics to detect biomarkers in seconds. […]
Funding snapshot
- Total raised
- $6.7MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $550K2025-12-19
Funding rounds
- Round, 2025
- $550K2025-12-19, SEC form D sold, 2 investors
- Round, 2023
- $2M2023-12-04, SEC form D sold, 1 investor
- Round, 2023
- $832K2023-02-27, SEC form D sold, 10 investors
- Round, 2021
- $255K2021-08-25, SEC form D sold, 4 investors
- Round, 2021
- $2.2M2021-03-08, SEC form D sold, 16 investors
- Round, 2020
- $300K2020-01-17, SEC form D sold, 2 investors
- Round, 2019
- $535K2019-03-01, SEC form D sold, 12 investors
Loading relationship preview